Fas antigen (CD95) expression and apoptosis in hepatocytes of patients with chronic viral hepatitis

被引:13
作者
Kiyici, M [1 ]
Gurel, S
Budak, F
Dolar, E
Gulten, M
Nak, SG
Memik, F
机构
[1] Uludag Univ, Fac Med, Dept Gastroenterol, TR-16059 Bursa, Turkey
[2] Uludag Univ, Fac Med, Dept Microbiol & Infect Dis, TR-16059 Bursa, Turkey
关键词
chronic viral hepatitis; apoptosis; Fas antigen;
D O I
10.1097/00042737-200310000-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Apoptosis may be defined as programmed cell death. It is involved in the normal development and homeostasis of tissues in multicellular organisms. An increased or decreased rate of apoptosis may lead to a range of diseases. Fas antigen is a cell-surface receptor that induces apoptotic pathways when treated with Fas ligand or anti-Fas antibody. There is increasing evidence that apoptosis plays an important role in the immunopathogenesis of chronic viral hepatitis, in which the Fas antigen-Fas ligand pathway is particularly involved. Methods Fas antigen expression and apoptosis (apoptotic index) were assayed using flow cytometry in the hepatocytes of 27 patients with chronic viral hepatitis. Histopathological activity, scored by Knodell's histological activity index, other histopathological parameters, serum transaminase values and patient age were then compared with apoptotic index and Fas antigen expression. Results Apoptosis and Fas antigen expression in hepatocytes were correlated closely with histological activity (grade) Of chronic viral hepatitis, but there were no correlations with histological stage, patient age or serum transaminase levels. Conclusion Apoptosis and its triggering molecule, Fas antigen, induce mechanisms that appear to be associated with the pathogenesis of chronic viral hepatitis. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:1079 / 1084
页数:6
相关论文
共 26 条
[1]  
Ando K, 1997, J IMMUNOL, V158, P5283
[2]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[3]  
Farinati F., 1998, Journal of Hepatology, V28, P177, DOI 10.1016/S0168-8278(98)80891-X
[4]  
Feray C., 1998, Journal of Hepatology, V28, P97, DOI 10.1016/S0168-8278(98)80584-9
[5]   INVOLVEMENT OF THE CD95 (APO-1/FAS) RECEPTOR AND LIGAND IN LIVER-DAMAGE [J].
GALLE, PR ;
HOFMANN, WJ ;
WALCZAK, H ;
SCHALLER, H ;
OTTO, G ;
STREMMEL, W ;
KRAMMER, PH ;
RUNKELL, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1223-1230
[6]   TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes [J].
Gressner, AM ;
Lahme, B ;
Mannherz, HG ;
Polzar, B .
JOURNAL OF HEPATOLOGY, 1997, 26 (05) :1079-1092
[7]  
HAMAZAKI K, 1995, ACTA MED OKAYAMA, V49, P227
[8]  
Higaki K, 1996, AM J PATHOL, V149, P429
[9]  
HIRAMATSU N, 1994, HEPATOLOGY, V19, P1354, DOI 10.1002/hep.1840190606
[10]   FORMULATION AND APPLICATION OF A NUMERICAL SCORING SYSTEM FOR ASSESSING HISTOLOGICAL ACTIVITY IN ASYMPTOMATIC CHRONIC ACTIVE HEPATITIS [J].
KNODELL, RG ;
ISHAK, KG ;
BLACK, WC ;
CHEN, TS ;
CRAIG, R ;
KAPLOWITZ, N ;
KIERNAN, TW ;
WOLLMAN, J .
HEPATOLOGY, 1981, 1 (05) :431-435